Keyword Analysis & Research: plexium
Keyword Research: People who searched plexium also searched
Search Results related to plexium on Search Engine
-
PLEXIUM
https://www.bing.com/alink/link?url=https%3a%2f%2fwww.plexium.com%2f&source=serp-local&h=%2bK7z%2bvqWyTJs4DFPikxphSGNEBUN3PFsOWTxZD2wOPA%3d&p=lw_gbt&ig=95B54F005CE14797B120B4D4DFC249F7&ypid=YN873x12298846334276410343
Oops! Something went wrong, please try again later.Add phone numberOops! Something went wrong, please try again later.Add hours
DA: 5 PA: 12 MOZ Rank: 35
-
Plexium | Prospective Discovery and Rational Design of …
https://www.plexium.com/
WEBPlexium is the premier, next-generation targeted protein degradation (TPD) company. We lead the way in the rational design and discovery of monovalent protein degraders …
DA: 72 PA: 79 MOZ Rank: 38
-
Plexium Announces $102m Financing to Advance Pipeline of …
https://www.plexium.com/plexium-announces-102m-financing-to-advance-pipeline-of-targeted-protein-degradation-therapies-and-technology-platform/
WEBFeb 23, 2022 · Plexium is a company that discovers and develops novel therapies based on its platform of targeted protein degradation (TPD), a modality that selectively degrades …
DA: 39 PA: 49 MOZ Rank: 64
-
Plexium Initiates Dosing in Phase 1 Study of PLX-4545, a Potent …
https://www.plexium.com/plexium-initiates-dosing-in-phase-1-study-of-plx-4545-a-potent-and-selective-degrader-of-the-transcription-factor-ikzf2/
WEBDec 12, 2023 · San Diego, California, December 12, 2023 – Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today reported that the …
DA: 52 PA: 11 MOZ Rank: 51
-
Abbvie and Plexium Enter into Multi-target Strategic Collaboration …
https://www.plexium.com/abbvie-and-plexium-enter-into-multi-target-strategic-collaboration-to-develop-and-commercialize-targeted-protein-degradation-therapies-for-neurological-conditions/
WEBApr 28, 2022 · Plexium, a company that develops and commercializes targeted protein degraders (TPD) for neurological diseases, has entered into a strategic collaboration …
DA: 75 PA: 4 MOZ Rank: 92
-
Plexium Announces $102M Financing To Advance Pipeline Of …
https://www.prnewswire.com/news-releases/plexium-announces-102m-financing-to-advance-pipeline-of-targeted-protein-degradation-therapies-and-technology-platform-301488513.html
WEBFeb 23, 2022 · Plexium is a biotech company that develops targeted protein degradation (TPD) therapies for cancer and other diseases. It has raised $102M from investors and …
DA: 79 PA: 85 MOZ Rank: 21
-
Amgen and Plexium Announce Multi-year, Drug Discovery …
https://www.plexium.com/amgen-and-plexium-announce-multi-year-drug-discovery-collaboration-to-identify-novel-targeted-protein-degradation-therapies/
WEBFeb 3, 2022 · Plexium, a targeted protein degradation company, and Amgen, a global biotechnology company, have signed a multi-year agreement to identify novel molecular …
DA: 52 PA: 93 MOZ Rank: 14
-
Plexium | LinkedIn
https://www.linkedin.com/company/plexium
WEBPlexium is a San Diego-based company that develops targeted protein degraders for cancer, neurodegeneration, and other diseases. Follow Plexium on LinkedIn to see its …
DA: 48 PA: 31 MOZ Rank: 55
-
Plexium Announces $35m Financing to Advance Pipeline of …
https://www.plexium.com/plexium-announces-35m-financing-to-advance-pipeline-of-novel-protein-degraders/
WEBJan 21, 2021 · Plexium is a biotech company that discovers and develops protein degrading therapeutics directed towards challenging drug targets. It uses its DELPhe platform to …
DA: 94 PA: 33 MOZ Rank: 85
